{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:07:34Z","timestamp":1792181254948,"version":"4.4.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01DK108328"],"award-info":[{"award-number":["U01DK108328"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01DK108326"],"award-info":[{"award-number":["U01DK108326"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01DK126365"],"award-info":[{"award-number":["U01DK126365"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2U24CA-086368"],"award-info":[{"award-number":["2U24CA-086368"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5UG1 CA287013"],"award-info":[{"award-number":["5UG1 CA287013"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sheikh Khalifa bin Zayed Foundation"},{"DOI":"10.13039\/100001784","name":"Pancreatic Cancer Action Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Early detection is key to improving survival and mortality from pancreatic cancer. Traditional periodic screening for cancer in an asymptomatic population is infeasible and not recommended for this low-incidence disease. We describe a novel approach we call \u201cheuriskance\u201d (hyou-ris-kance), wherein a systematic search for and 1-time workup of a \u201cheurisk\u201d (hyou-risk) leads to earlier detection of cancer. A heurisk is an early-warning sign with 3 defining characteristics: (1) the individual has a higher-than-threshold probability of having prevalent invasive cancer, (2) it is associated with a meaningful lead time to diagnosis, and (3) it is identifiable by a systematic and scalable process in the population. Heuriskance aims to systematically detect cancer with clinically meaningful lead time to clinical diagnosis, minimize the proportion of patients with advanced disease, and maximize treatment options, leading to increases in lead time\u2013adjusted 1-, 3-, and 5- year survival. A specific example of a heurisk for pancreatic cancer is glycemically defined new-onset diabetes and the Early Detection Initiative for Pancreatic Cancer (ClinicalTrials.gov identifier NCT04662879) an example of glycemically defined new-onset diabetes-based heuriskance. As heuriskance has no precedent, we provide (1) a tiered risk stratification approach (Define-Enrich-Find), (2) metrics for choosing a heurisk, (3) success metrics for strategy, and (4) phases 1-5 for evaluating the strategy in retrospective and prospective studies. Like all current cancer therapies, heuriskance aims to iteratively improve survival from a fatal disease using a pragmatic, evidence-based, systematic approach to its earlier detection. We apply the concept of heuriskance to pancreatic cancer, but it could be extended to other cancer types.<\/jats:p>","DOI":"10.1093\/jnci\/djaf291","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T11:48:28Z","timestamp":1759578508000},"page":"1353-1363","source":"Crossref","is-referenced-by-count":6,"title":["Heuriskance: a novel paradigm for systematic earlier detection of sporadic pancreatic cancer"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3924-0971","authenticated-orcid":false,"given":"Suresh T","family":"Chari","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, University of Texas MD Anderson Cancer Center , Houston, TX,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3051-8882","authenticated-orcid":false,"given":"Ziding","family":"Feng","sequence":"additional","affiliation":[{"name":"Public Health Sciences Division, Fred Hutchinson Cancer Center , Seattle, WA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3304-2704","authenticated-orcid":false,"given":"Bechien","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kaiser Permanente Southern California , Los Angeles, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Fisher","sequence":"additional","affiliation":[{"name":"Department of Surgery, Baylor College of Medicine , Houston, TX,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Kambadakone","sequence":"additional","affiliation":[{"name":"Department of Radiology, Massachusetts General Hospital , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2851-2257","authenticated-orcid":false,"given":"Ying-Qi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Public Health Sciences Division, Fred Hutchinson Cancer Center , Seattle, WA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7923-9978","authenticated-orcid":false,"given":"Anirban","family":"Maitra","sequence":"additional","affiliation":[{"name":"Sheikh Ahmed Center for Pancreatic Cancer Research, University of Texas MD Anderson Cancer Center , Houston, TX,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7665-4498","authenticated-orcid":false,"given":"Barbara","family":"Kenner","sequence":"additional","affiliation":[{"name":"Kenner Family Research Fund , New York, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5631-2826","authenticated-orcid":false,"given":"Lynn M","family":"Matrisian","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Action Network , El Segundo, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"2026081003525190800_djaf291-B1","doi-asserted-by":"crossref","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026081003525190800_djaf291-B2","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"2026081003525190800_djaf291-B3","first-page":"1067","article-title":"Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer","volume":"30","author":"Brune","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"2026081003525190800_djaf291-B4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/jamaoncol.2024.1930","article-title":"Pancreatic cancer surveillance and survival of high-risk individuals","volume":"10","author":"Blackford","year":"2024","journal-title":"JAMA Oncol"},{"key":"2026081003525190800_djaf291-B5","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1200\/JCO.22.00298","article-title":"The multicenter cancer of pancreas screening study: impact on stage and survival","volume":"40","author":"Dbouk","year":"2022","journal-title":"J Clin Oncol"},{"key":"2026081003525190800_djaf291-B6","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1200\/JCO.22.00194","article-title":"Pancreatic cancer surveillance in carriers of a germline CDKN2A pathogenic variant: yield and outcomes of a 20-year prospective follow-up","volume":"40","author":"Klatte","year":"2022","journal-title":"J Clin Oncol"},{"key":"2026081003525190800_djaf291-B7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jamaoncol.2024.5522","article-title":"Concerns regarding the utility of high-risk pancreatic cancer surveillance-reply","volume":"11","author":"Blackford","year":"2025","journal-title":"JAMA Oncol"},{"key":"2026081003525190800_djaf291-B8","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.gastro.2018.05.035","article-title":"Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance","volume":"155","author":"Canto","year":"2018","journal-title":"Gastroenterology"},{"key":"2026081003525190800_djaf291-B9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jama.2019.10232","article-title":"Screening for pancreatic cancer: US Preventive Services Task Force reaffirmation recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"key":"2026081003525190800_djaf291-B10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2025.06.025","article-title":"Risk of pancreatic cancer in glycemically defined new-onset diabetes: a prospective cohort study","author":"Chari","year":"2025","journal-title":"Gastroenterology"},{"key":"2026081003525190800_djaf291-B11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41591-023-02332-5","article-title":"A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories","volume":"29","author":"Placido","year":"2023","journal-title":"Nat Med"},{"key":"2026081003525190800_djaf291-B12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.pan.2023.04.009","article-title":"Machine learning versus regression for prediction of sporadic pancreatic cancer","volume":"23","author":"Chen","year":"2023","journal-title":"Pancreatology"},{"key":"2026081003525190800_djaf291-B13","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/MPA.0000000000001882","article-title":"Early detection of pancreatic cancer: applying artificial intelligence to electronic health records","volume":"50","author":"Kenner","year":"2021","journal-title":"Pancreas"},{"key":"2026081003525190800_djaf291-B14","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/MPA.0000000000000369","article-title":"Early detection of sporadic pancreatic cancer: strategic map for innovation\u2014a white paper","volume":"44","author":"Kenner","year":"2015","journal-title":"Pancreas"},{"key":"2026081003525190800_djaf291-B15","first-page":"e68","article-title":"Large-scale pancreatic cancer detection via non-contrast CT and deep learning","volume":"278","author":"Cao","year":"2023","journal-title":"Nat Med"},{"key":"2026081003525190800_djaf291-B16","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1053\/j.gastro.2022.06.066","article-title":"Radiomics-based machine-learning models can detect pancreatic cancer on prediagnostic computed tomography scans at a substantial lead time before clinical diagnosis","volume":"163","author":"Mukherjee","year":"2022","journal-title":"Gastroenterology"},{"key":"2026081003525190800_djaf291-B17","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/cancers17111886","article-title":"Predicting pancreatic ductal adenocarcinoma occurrence up to 10 years in advance using features of the main pancreatic duct in pre-diagnostic CT scans","volume":"17","author":"Wang","year":"2025","journal-title":"Cancers"},{"key":"2026081003525190800_djaf291-B18","doi-asserted-by":"crossref","first-page":"758958","DOI":"10.3389\/fonc.2021.758958","article-title":"Fibroblast-activated protein inhibitor PET\/CT: cancer diagnosis and management","volume":"11","author":"Kuyumcu","year":"2021","journal-title":"Front Oncol"},{"key":"2026081003525190800_djaf291-B19","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1148\/rg.2020200104","article-title":"Abbreviated MRI for hepatocellular carcinoma screening and surveillance","volume":"40","author":"An","year":"2020","journal-title":"Radiographics"},{"key":"2026081003525190800_djaf291-B20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med"},{"key":"2026081003525190800_djaf291-B21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.gastro.2018.05.023","article-title":"Model to determine risk of pancreatic cancer in patients with new-onset diabetes","volume":"155","author":"Sharma","year":"2018","journal-title":"Gastroenterology"},{"key":"2026081003525190800_djaf291-B22","author":"Blakeslee","year":"2023"},{"key":"2026081003525190800_djaf291-B23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.6004\/jnccn.2020.7798","article-title":"Potential cost-effectiveness of risk-based pancreatic cancer screening in patients with new-onset diabetes","volume":"20","author":"Schwartz","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"2026081003525190800_djaf291-B24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1148\/radiol.2021203936","article-title":"Interval and subsequent round breast cancer in a randomized controlled trial comparing digital breast tomosynthesis and digital mammography screening","volume":"300","author":"Hofvind","year":"2021","journal-title":"Radiology"},{"key":"2026081003525190800_djaf291-B25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1148\/radiol.211132","article-title":"A randomized trial comparing breast cancer incidence and interval cancers after tomosynthesis plus mammography versus mammography alone","volume":"303","author":"Pattacini","year":"2022","journal-title":"Radiology"},{"key":"2026081003525190800_djaf291-B26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jnci\/djz137","article-title":"Evaluating screening participation, follow-up, and outcomes for breast, cervical, and colorectal cancer in the PROSPR consortium","volume":"112","author":"Barlow","year":"2020","journal-title":"JNCI J Natl Cancer Inst"},{"key":"2026081003525190800_djaf291-B27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2468-1253(16)30079-6","article-title":"Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study","volume":"1","author":"Walter","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026081003525190800_djaf291-B28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/j.gastro.2007.10.040","article-title":"Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer","volume":"134","author":"Chari","year":"2008","journal-title":"Gastroenterology"},{"key":"2026081003525190800_djaf291-B29","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.cgh.2024.03.038","article-title":"Temporal trends in body composition and metabolic markers prior to diagnosis of pancreatic ductal adenocarcinoma","volume":"22","author":"Klatte","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026081003525190800_djaf291-B30","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1053\/j.gastro.2019.01.039","article-title":"Phases of metabolic and soft tissue changes in months preceding a diagnosis of pancreatic ductal adenocarcinoma","volume":"156","author":"Sah","year":"2019","journal-title":"Gastroenterology"},{"key":"2026081003525190800_djaf291-B31","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.pan.2020.07.410","article-title":"Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential benefits of early intervention: a retrospective study","volume":"20","author":"Singh","year":"2020","journal-title":"Pancreatology"},{"key":"2026081003525190800_djaf291-B32","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1053\/j.gastro.2020.11.052","article-title":"Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection","volume":"160","author":"Fahrmann","year":"2021","journal-title":"Gastroenterology"},{"key":"2026081003525190800_djaf291-B33","doi-asserted-by":"crossref","first-page":"217450","DOI":"10.1016\/j.canlet.2025.217450","article-title":"Lead time trajectory of blood-based protein biomarkers for detection of pancreatic cancer based on repeat testing","volume":"612","author":"Fahrmann","year":"2025","journal-title":"Cancer Lett"},{"key":"2026081003525190800_djaf291-B34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2468-1253(16)30106-6","article-title":"Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer","volume":"1","author":"Hart","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026081003525190800_djaf291-B35","doi-asserted-by":"crossref","first-page":"106659","DOI":"10.1016\/j.cct.2021.106659","article-title":"Early Detection Initiative: a randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma","volume":"113","author":"Chari","year":"2022","journal-title":"Contemp Clin Trials"},{"key":"2026081003525190800_djaf291-B36","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.pan.2024.09.015","article-title":"Prediction of pancreatic cancer in patients with new onset hyperglycemia: a modified ENDPAC model","volume":"24","author":"Chen","year":"2024","journal-title":"Pancreatology"},{"key":"2026081003525190800_djaf291-B37","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.pan.2025.05.005","article-title":"Identifying signs and symptoms of pancreatic cancer: a population-based study using electronic health records and natural language processing","volume":"25","author":"Chen","year":"2025","journal-title":"Pancreatology"},{"key":"2026081003525190800_djaf291-B38","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1001\/jama.2024.5814","article-title":"Cancer stage compared with mortality as end points in randomized clinical trials of cancer screening: a systematic review and meta-analysis","volume":"331","author":"Feng","year":"2024","journal-title":"JAMA"},{"key":"2026081003525190800_djaf291-B39","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1214\/23-AOAS1848","article-title":"Assessing screening efficacy in the presence of cancer overdiagnosis","volume":"18","author":"Huang","year":"2024","journal-title":"Ann Appl Stat"},{"key":"2026081003525190800_djaf291-B40","doi-asserted-by":"crossref","first-page":"e0565","DOI":"10.1097\/HC9.0000000000000565","article-title":"National Liver Cancer Screening Trial (TRACER) study protocol","volume":"8","author":"Singal","year":"2024","journal-title":"Hepatol Commun"},{"key":"2026081003525190800_djaf291-B41","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.3390\/cancers14194818","article-title":"Cell-free DNA-based multi-cancer early detection test in an asymptomatic screening population (NHS-Galleri): design of a pragmatic, prospective randomised controlled trial","volume":"14","author":"Neal","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026081003525190800_djaf291-B42","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/jnci\/djae251","article-title":"More efficient, smaller multicancer screening trials","volume":"117","author":"Sasieni","year":"2025","journal-title":"J Natl Cancer Inst"},{"key":"2026081003525190800_djaf291-B43","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","article-title":"Phases of biomarker development for early detection of cancer","volume":"93","author":"Pepe","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"2026081003525190800_djaf291-B44","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/jnci\/djn326","article-title":"Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design","volume":"100","author":"Pepe","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"2026081003525190800_djaf291-B45","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1373\/clinchem.2015.252163","article-title":"Early-phase studies of biomarkers: what target sensitivity and specificity values might confer clinical utility?","volume":"62","author":"Pepe","year":"2016","journal-title":"Clin Chem"},{"key":"2026081003525190800_djaf291-B46","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ejca.2011.03.003","article-title":"Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies","volume":"47","author":"Ben","year":"2011","journal-title":"Eur J Cancer"},{"key":"2026081003525190800_djaf291-B47","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrgastro.2013.49","article-title":"New insights into pancreatic cancer-induced paraneoplastic diabetes","volume":"10","author":"Sah","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026081003525190800_djaf291-B48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pathmechdis.3.121806.154305","article-title":"Pancreatic cancer","volume":"3","author":"Maitra","year":"2008","journal-title":"Annu Rev Pathol"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djaf291\/64555782\/djaf291.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/8\/1353\/64555782\/djaf291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/8\/1353\/64555782\/djaf291.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T07:53:05Z","timestamp":1786348385000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/118\/8\/1353\/8277931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":48,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,10,8]]},"published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djaf291","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2025,10,8]]}}}